BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  HSS Welcomes Patients Back to Moving Forward

  We are proud to have supported the community response to COVID-19 in many ways, including expansion of our famously rigorous infection control protocols.

  May 5, 2020

   · 

  2 min read
• Journal of Neuroinflammation Article Shows ZyVersa’s Inflammasome Inhibitor, IC 100, Improves Functional Outcomes in an Animal Model of Multiple Sclerosis

  ZyVersa Therapeutics, Inc., (ZyVersa) a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that the Journal of Neuroinflammation has published data showing that inflammasome inhibitor, I

  May 5, 2020

   · 

  4 min read
• Business

  OrthoLive Announces Connectivity Partnership With ELLKAY In Response To Expanding Telemedicine Community

  OrthoLive, the nation’s leading orthopedic telemedicine provider, has announced a partnership with ELLKAY, LLC, a leader in healthcare connectivity since 2002, to enhance interoperability and improve efficiencies for providers who use the OrthoLive application to provide telemedicine services.

  May 5, 2020

   · 

  2 min read
• Policy

  Miskin Law Bringing Class Action Over False Positive COVID-19 Test Results

  False positive test results cause distress and hardship at an Ontario long-term care facility.

  May 5, 2020

   · 

  1 min read